1.
Ann Intern Med
; 174(1): JC3, 2021 01.
Article
in English
| MEDLINE | ID: covidwho-1518748
ABSTRACT
SOURCE CITATION: RECOVERY Collaborative Group. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. 2020;396:1345-52. 33031764.
Subject(s)
Antiviral Agents/therapeutic use , COVID-19 Drug Treatment , Hospitalization , Lopinavir/therapeutic use , Ritonavir/therapeutic use , Administration, Oral , Aged , Antiviral Agents/administration & dosage , COVID-19/mortality , Drug Combinations , Female , Humans , Lopinavir/administration & dosage , Male , Multicenter Studies as Topic , Randomized Controlled Trials as Topic , Ritonavir/administration & dosage , SARS-CoV-2 , United Kingdom
2.
Ann Intern Med
; 173(8): JC41, 2020 10 20.
Article
in English
| MEDLINE | ID: covidwho-881504
ABSTRACT
SOURCE CITATION: Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020;383:517-25. 32492293.